| 0 | 💬 0 |
A Phase 1/2 Dose-Ranging Safety and Immunogenicity Study of mRNA-Based Candidate Pandemic Influenza Vaccines in Healthy Adults.
(academic.oup.com)
|
Clinical Infectious Diseases 2026-04-25 | #vaccination #influenza #rna #immunogenicity #safety |